255 related articles for article (PubMed ID: 31266306)
21. Comparative Glycomic Analysis of Sialyl Linkage Isomers by Sialic Acid Linkage-Specific Alkylamidation in Combination with Stable Isotope Labeling of α2,3-Linked Sialic Acid Residues.
Hanamatsu H; Nishikaze T; Tsumoto H; Ogawa K; Kobayashi T; Yokota I; Morikawa K; Suda G; Sho T; Nakai M; Miura N; Higashino K; Sekiya S; Iwamoto S; Miura Y; Furukawa JI; Tanaka K; Sakamoto N
Anal Chem; 2019 Nov; 91(21):13343-13348. PubMed ID: 31577134
[TBL] [Abstract][Full Text] [Related]
22. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
23. A MALDI-MS-based quantitative targeted glycomics (MALDI-QTaG) for total N-glycan analysis.
Kim KJ; Kim YW; Hwang CH; Park HG; Yang YH; Koo M; Kim YG
Biotechnol Lett; 2015 Oct; 37(10):2019-25. PubMed ID: 26063621
[TBL] [Abstract][Full Text] [Related]
24. Comparative glycomic profiling in esophageal adenocarcinoma.
Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
[TBL] [Abstract][Full Text] [Related]
25. Total plasma N-glycome changes during pregnancy.
Ruhaak LR; Uh HW; Deelder AM; Dolhain RE; Wuhrer M
J Proteome Res; 2014 Mar; 13(3):1657-68. PubMed ID: 24527664
[TBL] [Abstract][Full Text] [Related]
26. Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis.
Yamasaki Y; Nouso K; Miyahara K; Wada N; Dohi C; Morimoto Y; Kinugasa H; Takeuchi Y; Yasunaka T; Kuwaki K; Onishi H; Ikeda F; Miyake Y; Nakamura S; Shiraha H; Takaki A; Iwasaki Y; Amano M; Nishimura S; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):528-34. PubMed ID: 25168691
[TBL] [Abstract][Full Text] [Related]
27. MALDI-TOF mass spectrometry imaging for N-glycans on FFPE tissue sections of mouse NASH liver through Sialic acid Benzylamidation.
Saito T; Watanabe A; Nakano M; Matsuo K
Glycoconj J; 2021 Apr; 38(2):167-175. PubMed ID: 33710478
[TBL] [Abstract][Full Text] [Related]
28. Serum protein N-glycosylation in paediatric non-alcoholic fatty liver disease.
Blomme B; Fitzpatrick E; Quaglia A; De Bruyne R; Dhawan A; Van Vlierberghe H
Pediatr Obes; 2012 Apr; 7(2):165-73. PubMed ID: 22434757
[TBL] [Abstract][Full Text] [Related]
29. Relative quantitation of neutral and sialylated N-glycans using stable isotopic labeled d0/d5-benzoyl chloride by MALDI-MS.
Wang C; Wu Y; Zhang L; Liu BF; Lin Y; Liu X
Anal Chim Acta; 2018 Mar; 1002():50-61. PubMed ID: 29306413
[TBL] [Abstract][Full Text] [Related]
30. CSF N-Glycomics Using MALDI MS Techniques in Alzheimer's Disease.
Palmigiano A; Messina A; Bua RO; Barone R; Sturiale L; Zappia M; Garozzo D
Methods Mol Biol; 2018; 1750():75-91. PubMed ID: 29512066
[TBL] [Abstract][Full Text] [Related]
31. A New titania glyco-purification tip for the fast enrichment and efficient analysis of glycopeptides and glycans by MALDI-TOF-MS.
Hacı Mehmet K; İzzet A; Bekir S
J Pharm Biomed Anal; 2019 Sep; 174():191-197. PubMed ID: 31174130
[TBL] [Abstract][Full Text] [Related]
32. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
[TBL] [Abstract][Full Text] [Related]
33. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
[TBL] [Abstract][Full Text] [Related]
34. Particle-based N-linked glycan analysis of selected proteins from biological samples using nonglycosylated binders.
Sroka-Bartnicka A; Karlsson I; Ndreu L; Quaranta A; Pijnappel M; Thorsén G
J Pharm Biomed Anal; 2017 Jan; 132():125-132. PubMed ID: 27718394
[TBL] [Abstract][Full Text] [Related]
35. Distinguishing Benign and Malignant Thyroid Nodules and Identifying Lymph Node Metastasis in Papillary Thyroid Cancer by Plasma
Zhang Z; Reiding KR; Wu J; Li Z; Xu X
Front Endocrinol (Lausanne); 2021; 12():692910. PubMed ID: 34248851
[TBL] [Abstract][Full Text] [Related]
36. A lectin-based isolation/enrichment strategy for improved coverage of N-glycan analysis.
Guan F; Tan Z; Li X; Pang X; Zhu Y; Li D; Yang G
Carbohydr Res; 2015 Oct; 416():7-13. PubMed ID: 26335373
[TBL] [Abstract][Full Text] [Related]
37. BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics.
Miura Y; Hato M; Shinohara Y; Kuramoto H; Furukawa J; Kurogochi M; Shimaoka H; Tada M; Nakanishi K; Ozaki M; Todo S; Nishimura S
Mol Cell Proteomics; 2008 Feb; 7(2):370-7. PubMed ID: 17986439
[TBL] [Abstract][Full Text] [Related]
38. LC-MS/MS glycomics of idiopathic rapid eye movement sleep behavior disorder.
Dong X; Mondello S; Kobeissy F; Talih F; Ferri R; Mechref Y
Electrophoresis; 2018 Dec; 39(24):3096-3103. PubMed ID: 30168606
[TBL] [Abstract][Full Text] [Related]
39. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
40. Development and analysis of alpha 1-antitrypsin neoglycoproteins: the impact of additional N-glycosylation sites on serum half-life.
Lusch A; Kaup M; Marx U; Tauber R; Blanchard V; Berger M
Mol Pharm; 2013 Jul; 10(7):2616-29. PubMed ID: 23668542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
